AUTOAXLES.NSE News

In this briefing: Pitti Engineering Ltd. - Steady Volume Growth Validates Future Earnings Visibility VA Tech Wabag Ltd - Healthy Order Inflows Sustain Growth Outlook; Maintain BUY Hero Motocorp Ltd - Margin Stability, Global Scale-Up & Strong Demand Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact 1. Pitti Engineering Ltd. - Steady Volume Growth Validates Future Earnings Visibility Volume Growth Continues: Robust, broad-based demand, coupled with consistent execution, helped the company maintain healthy capacity utilisation during the quarter. As a result, total lamination volumes grew 21.1% YoY to 16,823 tonnes, and machined components volumes increased 7.7% YoY to 2,967 tonnes. Ensuring Steady Supply of Electrosteel: The company has secured a tie-up of BISapproved steel from mills in Korea and Japan. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact KNR Constructions Ltd - Weak Revenue and Margin Visibility; SELL J Kumar Infraprojects Ltd - Execution Is Key for Pick-Up in Revenue Growth; Retain BUY Tata Steel Ltd - Q3: Largely Inline; Europe Policy Reset Structurally Supportive 1. Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Sequential Margin Gains with Upside from Volume Recovery: Automotive Axle Ltd. (AAL) delivered a steady improvement in profitability, with EBITDA margins rising to 11.4% in Q3FY26, up from 10.5% in the preceding quarter and 10.8% in the corresponding period last year, reflecting effective cost management and an improved product mix. Management remains confident of achieving mid-teen EBITDA margins (13%+) in the near term, contingent on a recovery in market volumes. With higher capacity utilization and better fixed cost absorption expected in Q4FY26 and FY27, operating leverage is likely to further support margin expansion and sustain the upward trajectory in profitability Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact KNR Constructions Ltd - Weak Revenue and Margin Visibility; SELL J Kumar Infraprojects Ltd - Execution Is Key for Pick-Up in Revenue Growth; Retain BUY Tata Steel Ltd - Q3: Largely Inline; Europe Policy Reset Structurally Supportive 1. Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Sequential Margin Gains with Upside from Volume Recovery: Automotive Axle Ltd. (AAL) delivered a steady improvement in profitability, with EBITDA margins rising to 11.4% in Q3FY26, up from 10.5% in the preceding quarter and 10.8% in the corresponding period last year, reflecting effective cost management and an improved product mix. Management remains confident of achieving mid-teen EBITDA margins (13%+) in the near term, contingent on a recovery in market volumes. With higher capacity utilization and better fixed cost absorption expected in Q4FY26 and FY27, operating leverage is likely to further support margin expansion and sustain the upward trajectory in profitability Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact KNR Constructions Ltd - Weak Revenue and Margin Visibility; SELL J Kumar Infraprojects Ltd - Execution Is Key for Pick-Up in Revenue Growth; Retain BUY Tata Steel Ltd - Q3: Largely Inline; Europe Policy Reset Structurally Supportive 1. Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Sequential Margin Gains with Upside from Volume Recovery: Automotive Axle Ltd. (AAL) delivered a steady improvement in profitability, with EBITDA margins rising to 11.4% in Q3FY26, up from 10.5% in the preceding quarter and 10.8% in the corresponding period last year, reflecting effective cost management and an improved product mix. Management remains confident of achieving mid-teen EBITDA margins (13%+) in the near term, contingent on a recovery in market volumes. With higher capacity utilization and better fixed cost absorption expected in Q4FY26 and FY27, operating leverage is likely to further support margin expansion and sustain the upward trajectory in profitability Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Shortlist of High Conviction Philippines Equity Ideas - November 2025 Pop Mart (9992 HK) 25Q3 - The Decline in Stock Prices May Not Have Ended Yet Maruti Suzuki Ltd - Export-Led Growth Aids Performance Automotive Axles Ltd - New Business Model Unlocks Margin Upside Long Kia (000270 KS) Vs. Short Hyundai (005380 KS): Quant Model Hits Trigger Zone in Korean Autos 1. Shortlist of High Conviction Philippines Equity Ideas - November 2025 We are gradually building a high-conviction coverage of ideas for mid and small-cap companies in the Philippines. We established metrics focused on high ROCE, sustainable 10-15% YoY growth, robust balance sheets, and prudent capital allocation —essential elements for identifying potential multi-bagger opportunities. Our focus turns to the Q3 FY25 earnings season, where we provide brief previews on the names we cover as they report earnings over the course of the month. 2. Pop Mart (9992 HK) 25Q3 - The Decline in Stock Prices May Not Have Ended Yet Pop Mart’s 25Q3 results beat expectations, mainly driven by high growth of revenue attributed from operations overseas.

In this briefing: NOV Expands Globally: Inside Its Bold Play for Argentina, Saudi, & Beyond! Hanmi Pharm (128940 KS): Flagship Drugs Boost 3Q25 Result Amid Obesity Pipeline Progress China Life (2628 HK) - 3Q Net Earnings Almost Doubled on a High Base Maruti Suzuki Ltd - Export-Led Growth Aids Performance Automotive Axles Ltd - New Business Model Unlocks Margin Upside 1. NOV Expands Globally: Inside Its Bold Play for Argentina, Saudi, & Beyond! National Oilwell Varco (NOV) has reported its third-quarter 2025 financial outcomes amid a challenging macro environment. The company recorded revenues of $2.18 billion, down slightly from the previous quarter, reflecting a less than 1% year-over-year and sequential decline in oilfield activity. Net income stood at $42 million, or $0.11 per diluted share, while the adjusted EBITDA rose to $258 million, which is 11.9% of revenue. 2. Hanmi Pharm (128940 KS): Flagship Drugs Boost 3Q25 Result Amid Obesity Pipeline Progress Hanmi Pharm (128940 KS) has reported mixed performance for 3Q25.

In this briefing: HSIE Results Daily: Maruti Suzuki, Bank of Baroda, Union Bank of India, Phoenix Mills... India: Potential Free Float Changes & Passive Flows in November Maruti Suzuki Ltd - Export-Led Growth Aids Performance Automotive Axles Ltd - New Business Model Unlocks Margin Upside Shriram Finance Ltd. - Inline Quarter; Growth Outlook Optimistic! 1. HSIE Results Daily: Maruti Suzuki, Bank of Baroda, Union Bank of India, Phoenix Mills... Maruti Suzuki: Maruti Suzuki’s (MSIL) Q2FY26 EBITDA margin at 10.5% was in line with Bloomberg consensus estimate of 10.6%, but above our estimate of 10.2% We expect margins to improve going forward as capacity utilization improves on the back of higher PV demand, ramp-up of the Victoris model, and increasing exports We expect exports to continue to do well over the medium term, benefitting from the company’s efforts over the last few years to improve penetration across markets, including developed markets, and with a wider portfolio and improving mix Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Hanmi Pharm (128940 KS): Flagship Drugs Boost 3Q25 Result Amid Obesity Pipeline Progress Japan Morning Connection: AI Related Earnings from Fri and a Strong Tape Set to Send JP Higher China Life (2628 HK) - 3Q Net Earnings Almost Doubled on a High Base Maruti Suzuki Ltd - Export-Led Growth Aids Performance Automotive Axles Ltd - New Business Model Unlocks Margin Upside 1. Hanmi Pharm (128940 KS): Flagship Drugs Boost 3Q25 Result Amid Obesity Pipeline Progress Hanmi Pharm (128940 KS) has reported mixed performance for 3Q25. Despite flat topline and high R&D investment, mid-single digit growth in operating profit is the key highlight of 3Q25 result. Interim topline results of Phase 3 trials for efpeglenatide have raised expectations that the drug will establish itself as a "national obesity drug" based on excellent efficacy and proven safety. The company submitted clinical trial application to FDA for HM17321. Hanmi received FDA approval to initiate a Phase 2 clinical trial with HM15275, which is expected to commence this month. 2.

In this briefing: Japan Morning Connection: AI Related Earnings from Fri and a Strong Tape Set to Send JP Higher China Life (2628 HK) - 3Q Net Earnings Almost Doubled on a High Base Maruti Suzuki Ltd - Export-Led Growth Aids Performance Automotive Axles Ltd - New Business Model Unlocks Margin Upside Shriram Finance Ltd. - Inline Quarter; Growth Outlook Optimistic! 1. Japan Morning Connection: AI Related Earnings from Fri and a Strong Tape Set to Send JP Higher Decent Onsemi numbers point to a more broad-based recovery, but the end of the Nexperia disruption may be seen as negative for Rohm and Renesas Socionext +17% on Fri on Google's Willow news but likely to give it all back on poor guidance SEI, TDK, Lasertec and TEL all pointing up, Screen down on timing issue 2. China Life (2628 HK) - 3Q Net Earnings Almost Doubled on a High Base China Life reported a strong set of 3Q earnings, with 3Q25 net profit almost doubled on top of a high base in 3Q24 to RMB 126.9bn, marking a rise of 92% YoY and lifting the 9M25 result up by 61% YoY to RMB 167.8bn, close to the mid-point of profit alert.